Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar

BackgroundIn March 2020, the rapid spread of SARS-CoV-2 prompted global vaccination campaigns to mitigate COVID-19 disease severity and mortality. The 2-dose BNT162b2-mRNA vaccine effectively reduced infection and mortality rates, however, waning vaccine effectiveness necessitated the introduction o...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Remy Thomas, Ahmed Zaqout, Bakhita Meqbel, Umar Jafar, Nishant N. Vaikath, Abdullah Aldushain, Adviti Naik, Hibah Shaath, Neyla S. Al-Akl, Abdi Adam, Houda Y. A. Moussa, Kyung C. Shin, Rowaida Z. Taha, Mohammed Abukhattab, Muna A. Almaslamani, Nehad M. Alajez, Abdelilah Arredouani, Yongsoo Park, Sara A. Abdulla, Omar M. A. El-Agnaf, Ali S. Omrani, Julie Decock
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-03-01
Saila:	Frontiers in Immunology
Gaiak:	SARS-CoV-2 BNT162b2 booster immune response immunological memory
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1557426/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!